JBIO

Jade Biosciences, Inc. Common Stock

9.50 USD
-0.64
6.31%
1 day
-6.31%
5 days
-90.09%
1 month
-89.19%
3 months
-89.64%
6 months
-87.61%
Year to date
-89.91%
1 year
-98.64%
5 years
-98.81%
10 years
-98.81%
0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

261% more call options, than puts

Call options by funds: $2.75M | Put options by funds: $761K

92% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 13

38% more capital invested

Capital invested by funds: $57.8M [Q3] → $79.9M (+$22.2M) [Q4]

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

8.7% more ownership

Funds ownership: 95.76% [Q3] → 104.45% (+8.7%) [Q4]

5% more funds holding

Funds holding: 75 [Q3] → 79 (+4) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for JBIO.

Financial journalist opinion

We haven’t received any recent news articles for JBIO.

Charts implemented using Lightweight Charts™